Luteinizing Hormone

BOSTON — In this video exclusive, Andrea Dunaif, MD, discusses some of the latest research on polycystic ovary syndrome featured at the ENDO 2024.

Women with polycystic ovary syndrome could improve some reproduction hormone levels if they switch to a ketogenic diet, according to systematic review and meta-analysis published in the Journal of the Endocrine Society.

These are times when, under assault from the COVID-19 pandemic and many parts of government, those of us who are relatively powerless can seek to regain control by influencing what we can influence.

Researchers have identified two distinct subtypes of polycystic ovary syndrome associated with novel gene regions, a discovery that could improve disease diagnosis and potentially provide new pathways for drug targets.

Researchers observed a U-shaped relationship between circulating testosterone levels and fracture risk among a cohort of Australian men, with men with a midrange plasma testosterone concentration at lowest risk for sustaining any fracture or hip fracture during a decade of follow-up, according to findings from a community-based study published in The Journal of Clinical Endocrinology & Metabolism.

Apple recently announced that it will partner with the Harvard T.H. Chan School of Public Health and the NIH’s National Institute of Environmental Health Sciences to create the first long-term study on a large scale focused on menstrual cycles and gynecologic conditions. The Apple Women’s Health Study, using the capabilities of the Apple Watch, will inform screening and risk assessment of women’s health conditions, such as polycystic ovary syndrome, infertility, osteoporosis, pregnancy and menopausal transition.

An estimated 40% to 50% of childhood cancer survivors will experience an endocrine disorder in their lifetime. The risk varies according to cancer treatment and can persist for decades after diagnosis.